Related Experiment Video
Updated: Jan 27, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
HDAC6 is associated with the formation of aortic dissection in human
Xian Guo1, Ze-Min Fang1, Xiang Wei1,2,3,4
1Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Insights
Histone deacetylase HDAC6 is reduced in aortic dissection (AD), impacting extracellular matrix genes and providing a potential therapeutic target for AD treatment by modulating histone post-translational modifications.
Area of Science:
- Cardiovascular Biology
- Epigenetics
- Molecular Pathology
Background:
- Aortic dissection (AD) involves vascular smooth muscle cell loss, altered elastic fibers, and inflammation.
- The specific post-translational modification (PTM) mechanisms underlying AD pathogenesis remain largely unknown.
Purpose of the Study:
- To investigate the role of histone deacetylase HDAC6 in the molecular mechanisms of type A aortic dissection (TAAD).
- To identify specific histone PTMs regulated by HDAC6 in TAAD and their downstream targets.
Main Methods:
- Analyzed aortic tissue samples from TAAD patients and coronary artery disease (CAD) controls.
- Utilized chromatin immunoprecipitation (ChIP)-PCR to identify genes regulated by H3K23ac.
- Employed tubastatin A, an HDAC6 inhibitor, to explore downstream effects in vitro and in vivo.
Main Results:
- Reduced HDAC6 protein levels were observed in TAAD aortas compared to controls.
- Specific histone acetylation patterns (increased H3K23ac, H4K12ac; decreased H3K18ac, H4K8ac, H4K5ac) were associated with TAAD.
- H3K23ac enrichment was found in extracellular matrix-related genes in TAAD samples, and HDAC6 was shown to regulate H4K20me2 and p-MEK1/2.
Conclusions:
- HDAC6 plays a critical role in TAAD development through the regulation of H3K23ac, H4K20me2, and p-MEK1/2.
- Targeting HDAC6 and related histone PTMs offers a potential therapeutic strategy for TAAD.
Background:
The pathological features of aortic dissection (AD) include vascular smooth muscle cell (VSMC) loss, elastic fiber fraction, and inflammatory responses in the aorta. However, little is known about the post-translational modification mechanisms responsible for these biological processes.
Methods:
A total of 72 aorta samples, used for protein detection, were collected from 36 coronary artery disease (CAD, served as the control) patients and 36 type A AD (TAAD) patients. Chromatin immunoprecipitation (ChIP)-PCR was used to identify the genes regulated by H3K23ac, and tubastatin A, an inhibitor of HDAC6, was utilized to clarify the downstream mechanisms regulated by HDAC6.
Results:
We found that the protein level of histone deacetylase HDAC6 was reduced in the aortas of patients suffering from TAAD and that the protein levels of H4K12ac, and H3K23ac significantly increased, while H3K18ac, H4K8ac, and H4K5ac dramatically decreased when compared with CAD patients. Although H3K23ac, H3K18ac, and H4K8ac increased in the human VSMCs after treatment with the HDAC6 inhibitor tubastatin A, only H3K23ac showed the same results in human tissues. Notably, the results of ChIP-PCR demonstrated that H3K23ac was enriched in extracellular matrix (ECM)-related genes, including Col1A2, Col3A1, CTGF, POSTN, MMP2, TIMP2, and ACTA2, in the aortic samples of TAAD patients. In addition, our results showed that HDAC6 regulates H4K20me2 and p-MEK1/2 in the pathological process of TAAD.
Conclusions:
These results indicate that HDAC6 is involved in human TAAD formation by regulating H3K23ac, H4K20me2 and p-MEK1/2, thus, providing a strategy for the treatment of TAAD by targeting protein post-translational modifications (PTMs), chiefly histone PTMs.
Related Concept Videos
Formation of Species
Solution Formation
This selective...
Standard Enthalpy of Formation
Aortic Regurgitation I: Introduction
Formation of Complex Ions
Microtubule Formation

